1. Medtech Insight
  2. >>Business

Medtronic and UnitedHealthcare Encouraged By First-Year Results From Value-Based Agreement

 
• By Marion Webb

Medtronic and UnitedHealthcare have evidence that their year-old partnership is improving  health outcomes in diabetes patients that require intensive insulin delivery. An analysis of more than 6,000 UnitedHealthcare members with diabetes who used Medtronic's MiniMed 630G and previous generation insulin pumps between July 2016 and July 2017 showed 27% fewer preventable hospital admissions compared to plan-participants who were using multiple daily injections of insulin.

Low value
• Source: shutterstock.com

Medtronic PLC's agreement to provide continuous glucose monitor and insulin pump systems to [UnitedHealthCare] members improved patient-outcomes in the first year, according to an analysis announced July 10.

The companies analyzed more than 6,000 UnitedHealthcare members with diabetes who used Medtronic's MiniMed 630G and previous generation insulin pumps; they showed 27% fewer preventable hospital admissions vs. insurance participants who were on multiple daily injections of insulin

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight